Immune response against SARS-CoV-2 variants: the role of neutralization assays
Abstract Since the emergence of the novel coronavirus SARS-CoV-2 in late 2019, the COVID-19 pandemic has hindered social life and global economic activity. As of July 2021, SARS-CoV-2 has caused over four million deaths. The rapid spread and high mortality of the disease demanded the international s...
Guardado en:
Autores principales: | Alicja Maria Chmielewska, Anna Czarnota, Krystyna Bieńkowska-Szewczyk, Katarzyna Grzyb |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/774dca0f71354bdcbe9d1aea2f8b0c23 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
por: Mitch Brinkkemper, et al.
Publicado: (2021) -
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
por: Satoshi Ikegame, et al.
Publicado: (2021) -
MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
por: Sua Lee, et al.
Publicado: (2021) -
Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
por: Chaojie Zhong, et al.
Publicado: (2021) -
Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants
por: Wei-Shuo Lin, et al.
Publicado: (2021)